SONOMA PHARMACEUTICALS, INC. Foreign Currency Transaction Loss, before Tax
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Foreign Currency Transaction Loss, before Tax of $825.00 thousand for the 12-month period ending 2024-03-31, per its 10-K filed 2024-06-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2024-06-17
- SONOMA PHARMACEUTICALS, INC. foreign currency transaction loss, before tax for fiscal 2024 was $825.00K, a 19.22% increase from fiscal 2023.
- SONOMA PHARMACEUTICALS, INC. foreign currency transaction loss, before tax for fiscal 2023 was $692.00K, a 19.52% increase from fiscal 2022.
- SONOMA PHARMACEUTICALS, INC. foreign currency transaction loss, before tax for fiscal 2022 was $579.00K, a 16.09% decline from fiscal 2021.
- SONOMA PHARMACEUTICALS, INC. foreign currency transaction loss, before tax for fiscal 2021 was $690.00K, a 125.49% increase from fiscal 2020.
| Period end | Foreign Currency Transaction Loss, before Tax 12 month |
|---|---|
| 2024-03-31 | $825.00K 10-K · filed 2024-06-17 |
| 2023-03-31 | $692.00K 10-K · filed 2024-06-17 |
| 2022-03-31 | $579.00K 10-K · filed 2023-06-21 |
| 2021-03-31 | $690.00K 10-K · filed 2022-07-13 |
| 2020-03-31 | $306.00K 10-K · filed 2020-07-10 |
| 2019-03-31 | $162.00K 10-K · filed 2020-07-10 |
| 2018-03-31 | $208.00K 10-K · filed 2019-07-01 |
| 2017-03-31 | $208.00K 10-K · filed 2018-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |